Sökning: "prognostic risk factors"

Visar resultat 1 - 5 av 249 avhandlingar innehållade orden prognostic risk factors.

  1. 1. Risk and prognostic factors for malignant glioma

    Detta är en avhandling från Umeå : Umeå universitet

    Författare :Sara Sjöström; Umeå universitet.; [2012]
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Glioma; Glioblastoma; Risk; Outcome; EGR; EGFR; VEGF; VEGFR; DNA repair; virus; MEDICINE Surgery Oncology; MEDICIN Kirurgi Onkologi; onkologi; Oncology;

    Sammanfattning : Background: Glioblastoma is the most common and aggressive type of glioma and associated with poor prognosis. Apart from ionizing radiation and some rare genetic disorders, few aetiological factors have been identified for primary brain tumours. LÄS MER

  2. 2. Prognostic Factors in Malignant Melanoma

    Detta är en avhandling från Uppsala : Universitetsbiblioteket

    Författare :Åsa Bolander; Uppsala universitet.; [2008]
    Nyckelord :Malignant melanoma; prognostic factors; survival; chemotherapy; radiation;

    Sammanfattning : Because of the failure so far to find effective treatment for patients with advanced stages of melanoma, increasing efforts have been made to find prognostic factors identifying patients in the risk zone for development of metastasis.This thesis investigates the prognostic powers of a few selected serological and immunohistochemical biomarkers. LÄS MER

  3. 3. Interdisciplinary rehabilitation in patients with chronic pain : : prognostic factors and effectiveness

    Detta är en avhandling från Stockholm : Karolinska Institutet, Dept of Neurobiology, Care Sciences and Society

    Författare :Elena Tseli; Karolinska Institutet.; Karolinska Institutet.; [2019]
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES;

    Sammanfattning : Multimodal smärtrehabilitering (MMR) anses vara bästa praxis för behandling av kronisk smärta. De påvisade effekterna på olika (biopsykosociala) hälsorelaterade resultat är dock suboptimala. LÄS MER

  4. 4. Diabetes Mellitus at the Time for Diagnosis Studies on Prognostic Factors

    Detta är en avhandling från Uppsala : Acta Universitatis Upsaliensis

    Författare :Mats Martinell; Uppsala universitet.; [2017]
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; New-onset Diabetes Mellitus; socioeconomic position; epidemiology; diabetes complications; diabetic retinopathy; cellular immunology; diabetes classification; type 2 diabetes; latent autoimmune diabetes in adults LADA ; type 1 diabetes; Allmänmedicin; Family Medicine; Endokrinologi och Diabetologi; Endocrinology and Diabetology;

    Sammanfattning : The aim for this thesis was to identify prognostic factors for chronic diabetes complications that exist at the time of diabetes diagnosis.Low level of education (<12 years) and low income (<60% of median) was found to increase the risk to have high (>70 mmol/mol) HbA1c at the time of diagnosis with 34 % and 35 %, respectively. LÄS MER

  5. 5. Prevalence and Prognostic Impact of Periodontal Disease and Conventional Risk Factors in Patients with Stable Coronary Heart Disease

    Detta är en avhandling från Uppsala : Acta Universitatis Upsaliensis

    Författare :Ola Vedin; Uppsala universitet.; [2015]
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Coronary heart disease; Secondary prevention; Prevention; Periodontal Disease; Tooth loss; Risk prediction; Risk factors; Myocardial infarction; Cardiology; Kardiologi;

    Sammanfattning : The purpose of this thesis was to assess the prevalence and management of established cardiovascular (CV) risk factors and the prevalence and influence of self-reported markers (number of teeth and frequency of gum bleeding) of periodontal disease (PD), a less explored CV risk factor, in patients with stable chronic coronary heart disease (CHD).We studied patients from the global STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY (STABILITY) trial (n=15,828), in which patients with stable chronic CHD were randomized to either darapladib or placebo. LÄS MER